Autologous CLL T cells are well documented to have impaired proliferative and effector responses, dysregulation of the CD4/CD8 immune balance, and a terminally differentiated phenotype (39, 40, 66–68). Here, CD8A is linked to B-cell chronic lymphocytic leukemia.